jag009
★★★

NJ,
2015-05-02 09:27
(4075 d 11:16 ago)

Posting: # 14746
Views: 12,540
 

 Q1 / Q2 Guidance FDA [Regulatives / Guidelines]

Hi,

Does anyone know if there is some kind of FDA guidance on Q1 and Q2? I searched around and only find bits and pieces of information...

Thanks

John
luvblooms
★★  

India,
2015-05-04 08:55
(4073 d 11:49 ago)

@ jag009
Posting: # 14747
Views: 11,214
 

 Q1 / Q2: CFR 320 may be of some help

Hi John


❝ Does anyone know if there is some kind of FDA guidance on Q1 and Q2? I searched around and only find bits and pieces of information...


As of now even I am not aware of any specific Q1/Q2 guidance but there are sufficient information available in CFR's.

Do check these links
  1. Excipients: A Regulatory Support Prospective: Many CFR links are given for Solution, opthalmics and injections

  2. Criteria for waiver of evidence of in vivo bioavailability or bioequivalence.

  3. 21 CFR 320.22 - Criteria for waiver of evidence of in vivo bioavailability or bioequivalence

Hope this would be of some help!!!

~A happy Soul~
jag009
★★★

NJ,
2015-05-05 00:54
(4072 d 19:50 ago)

@ luvblooms
Posting: # 14748
Views: 10,835
 

 Q1 / Q2: CFR 320 may be of some help

Thanks Bloom,

Yes I found those info as well.

John
nobody
nothing

2015-05-05 13:19
(4072 d 07:25 ago)

@ jag009
Posting: # 14749
Views: 10,848
 

 Q1 / Q2: CFR 320 may be of some help


Kindest regards, nobody
UA Flag
Activity
 Admin contact
23,655 posts in 4,993 threads, 1,571 registered users;
367 visitors (0 registered, 367 guests [including 21 identified bots]).
Forum time: 20:44 CEST (Europe/Vienna)

The real struggle is not between the right and the left
but between the party of the thoughtful
and the party of the jerks.    Jimmy Wales

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5